Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.51 | N/A |
| PEG Ratio (TTM) | 2.57 | N/A |
| P/S Ratio (TTM) | 6.75 | N/A |
| P/B Ratio (TTM) | 5.36 | N/A |
| P/FCF Ratio (TTM) | 31.99 | N/A |
| Price to 5YR AVG Earnings Ratio | 37.93 | N/A |
| Price to 5YR AVG FCF Ratio | 50.93 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 16.24% | N/A |
| ROE (TTM) | 21.10% | N/A |
| Net Profit Margin (TTM) | 25.48% | N/A |
| ROIC 5YR AVG | 23.10% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 25.90% | 16.07% | 14.26% |
| Revenue | 5.89% | 14.23% | 9.56% |
| Net Income | 25.84% | 16.82% | 14.58% |
| Cash Flow | -4.13% | 9.22% | 16.02% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.30 | N/A |
| Quick Ratio (TTM) | 2.35 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 15.61 | N/A |
| LTL to 5YR AVG FCF | 0.14 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.29% | N/A |